Literature DB >> 21057361

Real-time free cortisol quantification among critically ill children.

Jerry J Zimmerman1, Amy Donaldson, Ruth M Barker, Kathleen L Meert, Rick Harrison, Joseph A Carcillo, Kanwaljeet J S Anand, Christopher J L Newth, John Berger, Douglas F Willson, Rhona Jack, Carol Nicholson, J Michael Dean.   

Abstract

OBJECTIVES: Ascertainment of adrenal function assessing free rather that total cortisol may be beneficial for the diagnosis of critical illness-related cortisol insufficiency. We hypothesized that centrifugal ultrafiltration would provide timely free cortisol data that highly correlated with the gold standard, but logistically cumbersome, equilibrium dialysis technique when the free cortisol fractions were identically quantified by chemiluminescence immunoassay. We also hypothesized that free cortisol would correlate with illness severity in a large cohort of critically ill children.
DESIGN: Prospective, multi-institutional, observational cohort investigation.
SETTING: Seven pediatric intensive care units within the Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network. PATIENTS: One hundred sixty-five critically ill children across the spectrum of illness severity.
INTERVENTIONS: Blood sampling.
MEASUREMENTS AND MAIN RESULTS: Time to derive plasma free cortisol concentrations after centrifugal ultrafiltration or equilibrium dialysis fractionation with chemiluminescence immunoassay was approximately 2 vs. approximately 24 hrs, respectively. Using centrifugal ultrafiltration, mean plasma free cortisol was 4.1 ± 6.7 μg/dL (median, 1.6 μg/dL; range, 0.2-43.6 μg/L), representing an average of 15.2 ± 9.4% of total cortisol. Nearly 60% of subjects exhibited free cortisol <2 and 30% <0.8 μg/dL, previously suggested threshold concentrations for defining critical illness-related cortisol insufficiency. Plasma-free cortisol concentrations comparing centrifugal ultrafiltration vs. equilibrium dialysis fractionation demonstrated a strong correlation (R2 = 0.97). For free cortisol <2 μg/dL, Bland-Altman analysis revealed minimal negative bias for the centrifugal ultrafiltration technique. Illness severity assessed by Pediatric Risk of Mortality III correlated moderately with free cortisol and percent total cortisol as free cortisol.
CONCLUSIONS: Determination of centrifugal ultrafiltration fractionated free cortisol was fast and results correlated highly with equilibrium dialysis fractionated free cortisol. Many children exhibited free cortisol <2 and <0.8 μg/dL but did not demonstrate clinical evidence of critical illness-related cortisol insufficiency. This study ascertains that real-time free cortisol quantification is feasible to potentially help guide clinical decision-making for cortisol replacement therapy in the pediatric intensive care unit.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21057361      PMCID: PMC3566572          DOI: 10.1097/PCC.0b013e3181fe4474

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  32 in total

1.  Glucocorticoid therapy in the intensive care unit.

Authors:  Lynn Loriaux
Journal:  N Engl J Med       Date:  2004-04-15       Impact factor: 91.245

2.  A prospective multicenter study of adrenal function in critically ill children.

Authors:  Kusum Menon; Roxanne E Ward; Margaret L Lawson; Isabelle Gaboury; James S Hutchison; Paul C Hébert
Journal:  Am J Respir Crit Care Med       Date:  2010-03-18       Impact factor: 21.405

Review 3.  The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation.

Authors:  G P Chrousos
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245

4.  Pituitary-adrenal responses to human corticotropin-releasing hormone in critically ill patients.

Authors:  Ioanna Dimopoulou; Panagiota Alevizopoulou; Urania Dafni; Stylianos Orfanos; Olga Livaditi; Marinella Tzanela; Anastasia Kotanidou; Emmanouil Souvatzoglou; Petros Kopterides; Irini Mavrou; Nikolaos Thalassinos; Charis Roussos; Apostolos Armaganidis; Stylianos Tsagarakis
Journal:  Intensive Care Med       Date:  2006-12-22       Impact factor: 17.440

5.  Septic shock and sepsis: a comparison of total and free plasma cortisol levels.

Authors:  J T Ho; H Al-Musalhi; M J Chapman; T Quach; P D Thomas; C J Bagley; J G Lewis; D J Torpy
Journal:  J Clin Endocrinol Metab       Date:  2005-11-01       Impact factor: 5.958

6.  Free cortisol in sepsis and septic shock.

Authors:  Stepani Bendel; Sari Karlsson; Ville Pettilä; Pekka Loisa; Marjut Varpula; Esko Ruokonen
Journal:  Anesth Analg       Date:  2008-06       Impact factor: 5.108

7.  Measurement of salivary cortisol concentration in the assessment of adrenal function in critically ill subjects: a surrogate marker of the circulating free cortisol.

Authors:  Baha M Arafah; Fumie J Nishiyama; Haytham Tlaygeh; Rana Hejal
Journal:  J Clin Endocrinol Metab       Date:  2007-05-29       Impact factor: 5.958

8.  Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding.

Authors:  Nigel J Waters; Rachel Jones; Gareth Williams; Bindi Sohal
Journal:  J Pharm Sci       Date:  2008-10       Impact factor: 3.534

9.  Hydrocortisone therapy for patients with septic shock.

Authors:  Charles L Sprung; Djillali Annane; Didier Keh; Rui Moreno; Mervyn Singer; Klaus Freivogel; Yoram G Weiss; Julie Benbenishty; Armin Kalenka; Helmuth Forst; Pierre-Francois Laterre; Konrad Reinhart; Brian H Cuthbertson; Didier Payen; Josef Briegel
Journal:  N Engl J Med       Date:  2008-01-10       Impact factor: 91.245

10.  Measurement of serum free cortisol shows discordant responsivity to stress and dynamic evaluation.

Authors:  Mirjam Christ-Crain; Sukhdeep Jutla; Isabelle Widmer; Orestes Couppis; Caroline König; Hans Pargger; Jardena Puder; Ray Edwards; Beat Müller; Ashley B Grossman
Journal:  J Clin Endocrinol Metab       Date:  2007-03-06       Impact factor: 5.958

View more
  8 in total

1.  Are we correctly diagnosing adrenal insufficiency or are we just spitting into the wind?

Authors:  Lara P Nelson; Barry P Markovitz
Journal:  Pediatr Crit Care Med       Date:  2015-05       Impact factor: 3.624

Review 2.  Regulation of cortisol bioavailability--effects on hormone measurement and action.

Authors:  Ilias Perogamvros; David W Ray; Peter J Trainer
Journal:  Nat Rev Endocrinol       Date:  2012-08-14       Impact factor: 43.330

Review 3.  Pediatric sepsis: challenges and adjunctive therapies.

Authors:  William Hanna; Hector R Wong
Journal:  Crit Care Clin       Date:  2013-01-03       Impact factor: 3.598

4.  Corticosteroids in Pediatric Shock: A Call to Arms.

Authors:  Kusum Menon; Hector R Wong
Journal:  Pediatr Crit Care Med       Date:  2015-10       Impact factor: 3.624

5.  Identifying critically ill patients who may benefit from adjunctive corticosteroids: not as easy as we thought.

Authors:  Sarah J Atkinson; Hector R Wong
Journal:  Pediatr Crit Care Med       Date:  2014-10       Impact factor: 3.624

6.  Hydrocortisone treatment is associated with a longer duration of MODS in pediatric patients with severe sepsis and immunoparalysis.

Authors:  Katherine E Bline; Melissa Moore-Clingenpeel; Josey Hensley; Lisa Steele; Kristin Greathouse; Larissa Anglim; Lisa Hanson-Huber; Jyotsna Nateri; Jennifer A Muszynski; Octavio Ramilo; Mark W Hall
Journal:  Crit Care       Date:  2020-09-04       Impact factor: 9.097

7.  A single nucleotide polymorphism in the corticotropin receptor gene is associated with a blunted cortisol response during pediatric critical illness.

Authors:  David Jardine; Mary Emond; Kathleen L Meert; Rick Harrison; Joseph A Carcillo; Kanwaljeet J S Anand; John Berger; Christopher J L Newth; Douglas F Willson; Carol Nicholson; J Michael Dean; Jerry J Zimmerman
Journal:  Pediatr Crit Care Med       Date:  2014-10       Impact factor: 3.624

Review 8.  Septic shock in pediatrics: the state-of-the-art.

Authors:  Pedro Celiny Ramos Garcia; Cristian Tedesco Tonial; Jefferson Pedro Piva
Journal:  J Pediatr (Rio J)       Date:  2019-12-13       Impact factor: 2.990

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.